Increased AI deployment results in an aggregated net hiring effect of +27% expected in 2026, while upskilling internal talent emerges as the primary strategy...
SINGAPORE, June 8, 2026 /PRNewswire/ -- Digital travel platform Agoda has recorded a rise in family accommodation searches for domestic summer travel compared to last...
SAN FRANCISCO, June 07, 2026 (GLOBE NEWSWIRE) -- On May 12, the Science x AI Summit 2026 held in Silicon Valley brought together numerous scientists, AI researchers, and industry institutions. Lim Meng Hoong, founder of MengHoong Intelligent Investment Academy, was invited to participate in the summit and engaged in discussions on the long-term impact of AI on scientific research systems and industrial structures. Unlike previous discussions centered on commercial applications, the summit this year placed greater emphasis on “how AI can drive scientific breakthroughs” and continued to advance international discussions around AI for Science.
BANDUNG, Indonesia, June 8, 2026 /PRNewswire/ -- TotalEnergies ENEOS successfully completed Phase 2 of a rooftop solar photovoltaic (PV) project with PT. Perusahaan Industri Ceres...
VESALIUS-CV Subgroup Results Show Repatha® Reduces Risk of First Major Cardiovascular Events by 29% in People Living with High-Risk DiabetesNew Real-World Data Highlight Treatment...
Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and SYNCHRONIZE-MASLD.2,4 The results demonstrate survodutide’s potential to reduce weight and therefore improve metabolic health in two distinct populations: adults living with obesity or overweight, without type 2 diabetes (SYNCHRONIZE-1),2 and adults with overweight or obesity with metabolic dysfunction-associated steatotic liver disease (MASLD) with evidence of inflammation and or fibrosis (SYNCHRONIZE-MASLD).4 Full results from SYNCHRONIZE-1 and SYNCHRONIZE-MASLD were presented today at the American Diabetes Association’s (ADA) 2026 Scientific Sessions and published simultaneously in The New England Journal of Medicine and Nature Medicine respectively.5,6
NEW YORK, June 7, 2026 /PRNewswire/ -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit...
ZURICH, June 07, 2026 (GLOBE NEWSWIRE) -- The cryptocurrency market is witnessing a massive convergence of artificial intelligence and digital culture. Investors are shifting capital toward functional crypto ecosystems. Memecoins have evolved far beyond basic internet jokes.
WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Badger Meter, Inc. (NYSE: BMI) between April 18, 2024 and April 16, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 3, 2026.
Pinellas Gulf Beach vacation rental and STR investment specialist places in the top 0.3% of residential real estate professionals in Florida, based on independently verified 2025 sales data
Pinellas Gulf Beach vacation rental and STR investment specialist places in the top 0.3% of residential real estate professionals in Florida, based on independently verified 2025 sales data
BulkQuant introduces an automated crypto trading app designed to help beginners access AI crypto trading bots with a simpler workflow, reduced manual operation, and clearer automation features.
BulkQuant introduces an automated crypto trading app designed to help beginners access AI crypto trading bots with a simpler workflow, reduced manual operation, and clearer automation features.
Diabetic ketoacidosis (DKA) can develop quickly and is not always easy to detect earlyKetone monitoring is not yet routine in diabetes care, which may...